Related Experiment Video
Updated: Sep 23, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
From risk detection to brain health action: The CheckPD-CheckBRAIN pathway across the missing middle in Parkinson's
Roongroj Bhidayasiri1, Jirada Sringean2, Saisamorn Phumphid2
1Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand; The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
Abstract:
Brain health has entered an implementation era, yet practical pathways for translating risk detection into meaningful action remain underdeveloped, particularly in low- and middle-income settings. Parkinson's disease (PD) offers a useful tracer condition for this challenge because it is common, progressive, clinically recognisable, functionally disabling, and highly sensitive to health-system capacity across awareness, referral, diagnosis, treatment, rehabilitation, caregiver support, and longitudinal monitoring. This review uses Thailand's CheckPD™ programme as an applied anchor for examining how digital PD screening can move beyond case-finding toward broader brain health implementation. CheckPD provides a population-facing digital screening and risk-stratification layer for PD and prodromal signals, but screening alone is insufficient. Without interpretation, risk communication, triage, referral completion, prevention advice, rehabilitation linkage, and follow-up, earlier detection may create earlier labelling rather than earlier benefit. We define this transition zone as the "missing middle." To address this gap, we propose CheckBRAIN™ as a post-screening brain health action framework organised around three domains: prevention pathways, resilience-building, and longitudinal brain health monitoring. Across primary prevention, CheckBRAIN promotes modifiable brain health and non-communicable disease risk reduction; across secondary prevention, it monitors risk trajectories, new prodromal symptoms, and conversion to clinical disease; and across tertiary prevention, it aims to preserve function, delay milestones, reduce complications, and support caregivers in established PD. By integrating prodromal PD risk science, digital screening, implementation science, resilience concepts, and global brain health strategy, the CheckPD-CheckBRAIN pathway offers a practical model for moving from early detection of neurodegeneration toward earlier, accessible, and actionable brain health care.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
The Blood-brain Barrier
